Balance Sheet

v3.25.4

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Dec. 31, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 216,890	$ 322,399
Accounts receivable, net	25,498	38,520
Inventory	40,495	50,082
Prepaid expenses and other current assets	13,368	18,145
Total current assets	296,251	429,146
Property and equipment, net	151,479	164,474
Goodwill	129,429	159,878
Intangible assets, net	151,543	194,957
Other assets	41,875	59,789
Total assets	770,577	1,008,244
Current liabilities:
Accounts payable	2,910	11,957
Accrued expenses and other current liabilities	36,567	39,574
Current portion of long-term debt	5,440	5,440
Total current liabilities	44,917	56,971
Long-term debt, less current portion	286,331	290,492
Finance lease liabilities, less current portion	30,141	31,106
Other long-term liabilities	36,477	52,466
Total liabilities	397,866	431,035
Commitments and contingencies (Note 9)
Stockholders’ equity:
Additional paid-in capital	199,177	181,874
Retained earnings	10,118	140,891
Accumulated other comprehensive income	524	0
Total stockholders’ equity attributable to Maravai LifeSciences Holdings, Inc.	212,379	325,292
Non-controlling interest	160,332	251,917
Total stockholders’ equity	372,711	577,209
Total liabilities and stockholders’ equity	770,577	1,008,244
Class A Common Stock
Stockholders’ equity:
Common stock	1,453	1,420
Class B Common Stock
Stockholders’ equity:
Common stock	$ 1,107	$ 1,107

- Definition

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

Source